ロード中...
A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections
Luliconazole is a novel imidazole derivative, which has demonstrated in vitro efficacy against dermatophytes and Candida. The results from Phase III trials show that luliconazole 1% cream applied once daily for 2 weeks successfully resolved the clinical signs and symptoms as well as eradicated the p...
保存先:
| 出版年: | Infect Drug Resist |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4723097/ https://ncbi.nlm.nih.gov/pubmed/26848272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S61998 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|